glp 1 agonist oral New GLP-1 Guidelines for Type 2 Diabetes in 2025 Oral Small-Molecule GLP-1 Receptor Agonists:
Description
Am J Physiol Endocrinol Metab 309: E1008E1018
Xin Y, Wang X, Zhu M, et al
As more patients and healthcare providers seek effective diabetes management solutions with minimal side effects, demand for GLP-1 receptor agonists is set to surge
Q: Can GLP-1 medications cause cancer
& Larsen, M
Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency
